EUDA Health Holdings Limited(EUDA)

Medical - Care Facilities · Singapore, CE

$19.30+2.00 (+11.57%)

Delayed quote: Oct 6, 2026, 2:14 PM EDT

Compare

EV/EBITDA Ratio: N/A

Name: EUDA Health Holdings Limited (EUDA) EV/EBITDA Ratio — historical time series
Creator: TGMCharts

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T18:16:39.675Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:16:39.675Z.

Quote observation: 2026-10-06T18:14:03.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 36,043,561
Total debt · period ending 2025-12-31: 2,401,371
Cash · period ending 2025-12-31: 345,145
TTM operating EBITDA · period ending 2025-12-31: -3,727,701

FMP input reference: c8d7801cb5d69976804150322740a3f9972799eb944d256c77d6faa31d53dc8f

EV/Sales|P/E Ratio|EBITDA|All Metrics

EV/EBITDA Ratio

EUDA EV/EBITDA Ratio Chart

N/A

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2022-07-29.

EUDA EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

EV/EBITDA RATIO AVG TTM

N/A

EV/EBITDA RATIO AVG 3Y

N/A

EV/EBITDA RATIO AVG 5Y

N/A

EV/EBITDA RATIO AVG 10Y

N/A

EV/EBITDA RATIO AVG 15Y

N/A

EV/EBITDA RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

EUDA Competitors' EV/EBITDA Ratio

EUDA

EUDA Health Holdings Limited

Current

Market Cap

$36.04M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

QTI

QT Imaging Holdings, Inc.

vs EUDA

Market Cap

$36.28M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ELTX

Elicio Therapeutics, Inc.

vs EUDA

Market Cap

$36.51M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DCGO

DocGo Inc.

vs EUDA

Market Cap

$35.57M

EV/EBITDA Ratio

N/A

TTM Avg

6.76x

3Y Avg

19.14x

5Y Avg

45.56x

EDSA

Edesa Biotech, Inc.

vs EUDA

Market Cap

$36.72M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BCTX

BriaCell Therapeutics Corp.

vs EUDA

Market Cap

$35.50M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GRCE

Grace Therapeutics, Inc.

vs EUDA

Market Cap

$34.50M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IXHL

Incannex Healthcare Limited

vs EUDA

Market Cap

$37.81M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NEPH

Nephros, Inc.

vs EUDA

Market Cap

$37.89M

EV/EBITDA Ratio

19.30x

TTM Avg

31.88x

3Y Avg

41.18x

5Y Avg

41.18x

ELUT

Elutia Inc

vs EUDA

Market Cap

$34.04M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
EUDA Health Holdings Limited (EUDA)	$36.04M	N/A	N/A	N/A	N/A
QT Imaging Holdings, Inc. (QTI)vs ›	$36.28M	N/A	N/A	N/A	N/A
Elicio Therapeutics, Inc. (ELTX)vs ›	$36.51M	N/A	N/A	N/A	N/A
DocGo Inc. (DCGO)vs ›	$35.57M	N/A	6.76x	19.14x	45.56x
Edesa Biotech, Inc. (EDSA)vs ›	$36.72M	N/A	N/A	N/A	N/A
BriaCell Therapeutics Corp. (BCTX)vs ›	$35.50M	N/A	N/A	N/A	N/A
Grace Therapeutics, Inc. (GRCE)vs ›	$34.50M	N/A	N/A	N/A	N/A
Incannex Healthcare Limited (IXHL)vs ›	$37.81M	N/A	N/A	N/A	N/A
Nephros, Inc. (NEPH)vs ›	$37.89M	19.30x	31.88x	41.18x	41.18x
Elutia Inc (ELUT)vs ›	$34.04M	N/A	N/A	N/A	N/A

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EUDA EV/EBITDA Ratio History

DATE	EV/EBITDA RATIO
2022-07-29	11037.82x
2022-07-28	11037.82x
2022-07-27	11037.82x
2022-07-26	11037.82x
2022-07-25	11026.72x
2022-07-22	11026.72x
2022-07-21	11026.72x
2022-07-20	11026.72x
2022-07-19	11037.82x
2022-07-18	11026.72x
2022-07-15	11015.62x
2022-07-14	11004.51x
2022-07-13	11004.51x
2022-07-12	11004.51x
2022-07-11	11015.62x
2022-07-08	10993.41x
2022-07-07	10993.41x
2022-07-06	10982.31x
2022-07-05	10982.31x
2022-07-01	10982.31x
2022-06-30	10982.31x
2022-06-29	10982.31x
2022-06-28	10971.21x
2022-06-27	10971.21x
2022-06-24	11004.51x
2022-06-23	11004.51x
2022-06-22	10971.21x
2022-06-21	10982.31x
2022-06-17	10982.31x
2022-06-16	10982.31x
2022-06-15	10971.21x
2022-06-14	10971.21x
2022-06-13	10971.21x
2022-06-10	10976.76x
2022-06-09	10976.76x
2022-06-08	10976.76x
2022-06-07	10976.76x
2022-06-06	10965.66x
2022-06-03	10965.66x
2022-06-02	10965.66x
2022-06-01	10965.66x
2022-05-31	10965.66x
2022-05-27	10949.01x
2022-05-26	10949.01x
2022-05-25	10982.31x
2022-05-24	10982.31x
2022-05-23	10982.31x
2022-05-20	10982.31x
2022-05-19	10960.11x
2022-05-18	10960.11x
2022-05-17	10960.11x
2022-05-16	10960.11x
2022-05-13	10960.11x
2022-05-12	10960.11x
2022-05-11	10971.21x
2022-05-10	10949.01x
2022-05-09	10949.01x
2022-05-06	10984.53x
2022-05-05	10982.31x
2022-05-04	10971.21x
2022-05-03	10993.41x
2022-05-02	10993.41x
2022-04-29	10993.41x

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics